Management of Child and Adolescent Stuttering with Olanzapine: Three Case Reports

Authors: Lavid N.; Franklin D.L.; Maguire G.A.

Source: Annals of Clinical Psychiatry, Volume 11, Number 4, December 1999 , pp. 233-236(4)

Publisher: Springer

Buy & download fulltext article:

Price: $47.00 plus tax (Refund Policy)

Abstract:

Vast arrays of medications have been used, with limited success, to manage stuttering. Haloperidol and risperidone are the only two medications that have shown efficacy via double-blind studies in controlling stuttering symptoms. We present the first case reports of olanzapine in the management of stuttering. Three case histories are presented: a 10-year-old boy, a 16-year-old male adolescent with developmental stuttering, and a 9-year-old boy with medication-induced stuttering whose symptoms are successfully controlled with olanzapine. These case studies suggest that olanzapine may be a pharmacologic option in the management of stuttering.

Keywords: Stuttering; olanzapine; childhood; adolescent

Language: English

Document Type: Research article

Affiliations: 1: Department of Psychiatry and Human Behavior, University of California at Irvine Medical Center, Orange, California 92868

Publication date: 1999-12-01